Literature DB >> 21257156

Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2.

Subhadra Jalali1, Siddharth Kesarwani, Anjli Hussain.   

Abstract

PURPOSE: To report the outcomes of zone 1 aggressive posterior retinopathy of prematurity (ROP) treated with aggressive laser photocoagulation by a protocol-based approach over a 10-year period.
DESIGN: Prospective, interventional case series.
SETTING: Tertiary eye institute and neonatal intensive care units in the twin cities of Hyderabad and Secunderabad in South India. STUDY POPULATION: Babies screened under the Indian Twin Cities Retinopathy of Prematurity Screening (ITCROPS) program between January 1, 1997 and March 31, 2007. INTERVENTION: Multiple sessions of laser photocoagulation at any sign of plus disease with abnormal shunt vessels with or without neovascularization in zone 1. OUTCOME MEASURE: Based on the anatomic status of the retina at the final follow-up, the outcome was classified into good (completely regressed with no vitreoretinal changes), fair (regression with vitreoretinal distortion), or poor (progression into partial or total retinal detachment involving macula). Descriptive statistics (mean and range) were used for gestational age at birth, birth weight, and post-conceptional age at first presentation and at the first intervention. Trends in incidence of zone 1 ROP over 1 decade were analyzed. Outcomes were expressed in terms of proportions and 95% confidence interval (CI).
RESULTS: Of the 3654 babies screened, 227 eyes of 115 babies were detected to have zone 1 aggressive disease, defined as zone 1 retinal vessels having abnormal closed-loop shunts, dilation and tortuosity, flat new vessels, or rapid progression. Laser was performed in 169 eyes. Disease regressed with good outcome in 142 eyes (84%) (95% CI, 77.6-89.2) and progressed to poor outcome in 13 eyes (7.69%) (95% CI, 4.1-12.8), while fair outcome was seen in 6 eyes (3.55%) (95% CI, 1.3-7.5). Thus 148 babies (87.5%) (95% CI, 81.6-92.14) had a favorable outcome. The outcomes in 8 treated eyes (4.7%) lost to follow-up were unknown.
CONCLUSIONS: Zone 1 aggressive ROP has a good outcome if the screening is done early; intervention is prompt and adequate, with frequent follow-up until complete regression is achieved.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21257156     DOI: 10.1016/j.ajo.2010.10.007

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity - 27 month follow-up results from Turkey.

Authors:  Huseyin Yetik; Murat Gunay; Sarkis Sirop; Ziya Salihoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-14       Impact factor: 3.117

2.  Smouldering retinopathy of prematurity: a case treated by multiple antivascular endothelial growth factor therapy.

Authors:  Divya Balakrishnan; Vikas Ambiya; Subhadra Jalali; Padmaja Kumari Rani
Journal:  BMJ Case Rep       Date:  2016-08-29

3.  Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.

Authors:  Christopher K Hwang; G Baker Hubbard; Amy K Hutchinson; Scott R Lambert
Journal:  Ophthalmology       Date:  2015-02-14       Impact factor: 12.079

4.  Outcome of solid-state 532 nm green laser in high-risk retinopathy of prematurity at a tertiary care centre in India.

Authors:  Kanika Chhabra; Prempal Kaur; Karamjit Singh; Anand Aggarwal; Dharamvir Chalia
Journal:  Int Ophthalmol       Date:  2017-02-15       Impact factor: 2.031

5.  Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  David Morrison; James Shaffer; Gui-Shuang Ying; Gil Binenbaum
Journal:  J AAPOS       Date:  2018-03-14       Impact factor: 1.220

6.  The use of digital imaging in the identification of skip areas after laser treatment for retinopathy of prematurity and its implications for education and patient care.

Authors:  Kai B Kang; Anton Orlin; Thomas C Lee; Michael F Chiang; R V Paul Chan
Journal:  Retina       Date:  2013 Nov-Dec       Impact factor: 4.256

7.  Characteristics and outcomes of anterior hyaloidal fibrovascular proliferation in lasered retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Study (ITCROPS) report number 4.

Authors:  Vivek Pravin Dave; Subhadra Jalali; Padmaja Kumari Rani; Tapas Ranjan Padhi
Journal:  Int Ophthalmol       Date:  2013-09-14       Impact factor: 2.031

Review 8.  Aggressive posterior retinopathy of prematurity: a review on current understanding.

Authors:  Devesh Kumawat; Anusha Sachan; Pooja Shah; Rohan Chawla; Parijat Chandra
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

9.  Use of intravitreal anti-VEGF: retinopathy of prematurity surgeons' in Hamlet's dilemma?

Authors:  Rajvardhan Azad; Vivek Dave; Subhadra Jalali
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

Review 10.  Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.

Authors:  Hannah Blencowe; Joy E Lawn; Thomas Vazquez; Alistair Fielder; Clare Gilbert
Journal:  Pediatr Res       Date:  2013-12       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.